Jim Cramer Says These Are the 5 Stocks to Buy During This Market Rotation
CNBC's Jim Cramer said Monday that investors should not fear the latest market rotation. Instead, he believes he is creating…
Johnson & Johnson
Cramer Says Look For These 4 Stocks To Pair With Your High-Flying Tech Names
CNBC's Jim Cramer said Thursday that investors should look beyond the market's hottest trades and start looking for opportunities in…
Eli Lilly to acquire cancer drug maker Kelonia in deal worth up to $7 billion
Eli Lilly will acquire biotech company Kelonia Therapeutics in a deal worth up to $7 billion, the company said Monday.…
Trump prepares pharmaceutical tariffs of up to 100%
The Trump administration on Thursday imposed new tariffs on brand-name drugs from pharmaceutical companies that have not reached agreements with…
J&J's Icotyde Psoriasis Pill Rivals Tremfya Skyrizi IL-23 Injections
Signs outside the Johnson & Johnson offices in Irvine, California, U.S., on Friday, October 10, 2025. Kyle Grillot Bloomberg |…
FDA Vaccine Director to Resign in April After Series of Controversial Decisions
The Food and Drug Administration logo before a news conference at Health and Human Services Headquarters in Washington, April 22,…
More medications should be available over the counter
Food and Drug Administration Commissioner Marty Makary told CNBC that he believes “everything should be over-the-counter” unless a drug is…
Nine pharmaceutical companies sign agreements with Trump to lower drug prices
US President Donald Trump speaks during an event in the Roosevelt Room of the White House on December 19, 2025…
Mergers and acquisitions in biotech and pharmaceuticals will recover in 2025
The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) on December 5, 2023. New York Stock Exchange Group…
FDA approves Johnson & Johnson's Spravato nasal spray for depression
This photo provided by Janssen Global Services shows Spravato nasal spray. Janssen Global Services via AP The Food and Drug…